T1	Participants 190 221	neurally mediated syncope (NMS)
T2	Participants 315 415	Eight previously characterized patients with recurrent NMS (five females and three males; 34+/-2 yr)
T3	Participants 468 494	eight age-matched controls
T4	Participants 1607 1624	patients with NMS
